subject: Aarkstore Enterprise---manufacturing Of Biologics - Increasing Demand For Monoclonal Antibodies And [print this page] GBI Research's report, Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies, provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry.
The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts to provide a comprehensive view of the manufacturing of biologics.
Scope
The scope of this report includes:
Opportunities and challenges for manufacturers of biologics in the pharmaceuticals industry
Market revenues and forecasts for biologics manufacturing in the global pharmaceutical industry from 2009 to 2016.
The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.
Processes involving the manufacturing of biologics including upstream and downstream bioprocessing.
Technology trends in upstream and downstream bioprocessing that shape the biomanufacturing industry and regulatory trends in the key markets.
Production capacities for the mammalian and microbial manufacturing facilities in the key regions.
Qualitative analysis of the market drivers, barriers, future outlook and challenges for the manufacturing of biologics in the pharmaceutical industry
Analysis of competitive landscape and the leading market players.
